| Quality of Tuberculosis Care in Urban Patna, India (NCT02874716) | McGill University | 2015-01-01 |
| A Phase I Study of Safety & Immunogenicity of AERAS-456 in HIV-Neg. Adults Treated for Drug-susceptible Pulmonary TB (NCT02375698) | Aeras | 2014-11-21 |
| Safety, Tolerance and Pharmacokinetics of Raltegravir-Containing Antiretroviral Therapy in Infants, Children Infected With HIV and TB (NCT01751568) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-11-12 |
| Phase IIb Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 (NCT02336542) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2014-11-01 |
| Safety of doTBal® in Patients With Tuberculosis: Conduction of an Intensive Pharmacovigilance Program (NCT04916899) | Laboratorios Silanes S.A. de C.V. | 2014-11-01 |
| A Phase 2 to Evaluate the Efficacy, Safety and Tolerability of Combinations of Bedaquiline, Moxifloxacin, PA-824 and Pyrazinamide in Adult Subjects With Drug-Sensitive or Multi Drug-Resistant Pulmonary Tuberculosis. (NCT02193776) | Global Alliance for TB Drug Development | 2014-10-23 |
| Concomitant Infections of Mansonella Perstans in Tuberculosis and Buruli Ulcer Disease Patients From Ghana (NCT02281643) | Kwame Nkrumah University of Science and Technology | 2014-10-01 |
| Rewards for Tuberculosis Contact Screening (NCT02234908) | Boston University | 2014-10-01 |
| Evaluation of the QuantiFERON-TB Test. (NCT02256839) | QIAGEN Gaithersburg, Inc | 2014-10-01 |
| Study to Evaluate the Efficacy of GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine in Adults (NCT01755598) | GlaxoSmithKline | 2014-08-19 |
| Evaluating the Safety of Immediate Versus Deferred Isoniazid Preventive Therapy Among HIV-Infected Pregnant Women (NCT01494038) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-08-19 |
| High-Dose Isoniazid Among Adult Patients With Different Genetic Variants of INH-Resistant Tuberculosis (TB) (NCT01936831) | Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections | 2014-08-13 |
| Substudy of Protocol TB-018 (NCT01755598): Collection and Storage of Biological Samples for Evaluation of Correlates of TB (C-041-972) (NCT02097095) | Aeras | 2014-08-01 |
| Rapid Detection of Rifampin and Isoniazid Resistance by PCR Before Tuberculosis (TB) Treatment Initiation (NCT02231229) | Assistance Publique - Hôpitaux de Paris | 2014-07-23 |
| Trial to Investigate the Effect of Schistosoma Mansoni Infection on the Response to Vaccination With MVA85A in BCG-vaccinated African Adolescents (NCT02178748) | University of Oxford | 2014-06-01 |
| The Serum Angiotensin Converting Enzyme and Lysozyme Levels in Patients Non-infectious and Infectious Uveitis (NCT02627209) | Ozlem Sahin | 2014-06-01 |
| Challenge Model for Assessment of Human TB Immunity (NCT01868464) | National Institute of Allergy and Infectious Diseases (NIAID) | 2014-05-28 |
| Evaluation of the QuantiFERON-TB Test. (NCT02142894) | QIAGEN Gaithersburg, Inc | 2014-05-27 |
| A Trial on Clinical Efficacy of 1% Versus 2% Lignocaine in Cough Suppression and Pain Relief in Patients Undergoing Flexible Bronchoscopy (NCT01955824) | Post Graduate Institute of Medical Education and Research, Chandigarh | 2014-05-01 |
| TB-IRIS NSAID Cox-2 Inhibitor Prevention Trial (NCT02060006) | University of Stellenbosch | 2014-04-01 |
| Effect of HIV and/or Active Tuberculosis on the Immune Responses to Trivalent Influenza Vaccine (TIV) in Adults (NCT01811823) | University of Witwatersrand, South Africa | 2014-03-31 |
| Innovative Approach in Tuberculosis Care in Armenia (NCT02082340) | Varduhi Petrosyan | 2014-03-01 |
| TB Immunotherapy Trial With Heat-killed M. Vaccae (NCT01977768) | Immunitor LLC | 2014-03-01 |
| Antiretroviral Therapy and Inflammatory and Coagulation Biomarkers: iMACS Study (NCT02027480) | Columbia University | 2014-03-01 |
| A Clinical Challenge Study of BCG in Healthy Volunteers (NCT02088892) | University of Oxford | 2014-03-01 |
| Safety and Immunogenicity of Nyaditum Resae® Probiotic to Protect From Tuberculosis (NCT02076139) | Manresana de Micobacteriologia, SL | 2014-03-01 |
| Evaluation of an Enhanced Tuberculosis Infection Control Intervention in Healthcare Facilities in Vietnam and Thailand (NCT02073240) | Centers for Disease Control and Prevention | 2014-02-17 |
| Phase IIa Clinical Study of Recombinant Mycobacterium Tuberculosis Allergen ESAT6-CFP10 (NCT02329730) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2014-02-01 |
| Evaluation of Safety, Immunogenicity, and Prevention of TB With AERAS-404 and BCG Revaccination in Healthy Adolescents (NCT02075203) | Aeras | 2014-02-01 |
| Evaluation of Non-Inferiority of Two Fast Follower Nucleic Acid Amplification Tests (NCT02252198) | Johns Hopkins University | 2014-02-01 |
| Paradoxical Tuberculosis Immune Reconstitution Inflammatory Syndrome (TB-IRIS) Treatment Trial (NCT01442428) | University of Minnesota | 2014-01-01 |
| Impact of Nursing Interventions on Adherence to Treatment With Anti-tuberculosis Drugs in Children and Adolescents (NCT03230409) | Hospital Sant Joan de Deu | 2014-01-01 |
| Biologic Basis Of Increased Susceptibility Of Smokers To Pulmonary Infection With Mycobacterium Tuberculosis (NCT02021747) | Weill Medical College of Cornell University | 2014-01-01 |
| Interaction Between High Dose Rifampicine and Efavirenz in Pulmonary Tuberculosis and HIV Co-infection (NCT01986543) | ANRS, Emerging Infectious Diseases | 2013-12-01 |
| DNA Sequencing of MDR TB in Eastern Siberia (NCT02508610) | University of Virginia | 2013-11-01 |
| Wirelessly Observed Therapy in Comparison to Directly Observed Therapy for the Treatment of Tuberculosis (NCT01960257) | University of California, San Diego | 2013-10-25 |
| Pharmacokinetic Parameters of Co-trimoxazole (NCT01832987) | University Medical Center Groningen | 2013-10-01 |
| The Utility of Intensified Case Finding Combined With a Package of Novel TB Diagnostics Using a Mobile Clinic in Africa (NCT01990274) | University of Cape Town | 2013-10-01 |
| Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration Responses (NCT01779102) | Statens Serum Institut | 2013-10-01 |
| Phase III Clinical Study of Efficacy and Safety of Vaccae™ to Prevent Tuberculosis (NCT01979900) | Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd. | 2013-10-01 |
| Study Evaluating Aerosol and Intradermal Administration of a Candidate Tuberculosis (TB) Vaccine, MVA85A, as a Way to Increase Immune Response and Avoid Anti-vector Immunity (NCT01954563) | University of Oxford | 2013-10-01 |
| Reactogenicity, Safety and Immunogenicity of a TB/FLU-01L Tuberculosis Vaccine (NCT03017378) | Research Institute for Biological Safety Problems | 2013-10-01 |
| Reactogenicity, Safety and Immunogenicity of a TB/FLU-04L Tuberculosis Vaccine (NCT02501421) | Research Institute for Biological Safety Problems | 2013-10-01 |
| Trial of High-Dose Rifampin in Patients With TB (NCT01408914) | Harvard University Faculty of Medicine | 2013-09-01 |
| Preventing TB-IRIS in High-risk Patients: a Randomized Placebo-controlled Trial of Prednisone (NCT01924286) | University of Cape Town | 2013-08-30 |
| Performance of IGRAs for TB Infection Diagnosis in Elderly (NCT01895582) | Assistance Publique - Hôpitaux de Paris | 2013-07-17 |
| Evaluation of an Innovative Tuberculosis Diagnostic Test (NCT02573623) | ANRS, Emerging Infectious Diseases | 2013-07-01 |
| Safety Study of ChAdOx1 85A Vaccination With and Without MVA85A Boost in Healthy Adults (NCT01829490) | University of Oxford | 2013-07-01 |
| ENhance Initiation and Retention in Isoniazid Preventive Therapy (IPT) Care for HIV Study (ENRICH Study) (NCT01926379) | Columbia University | 2013-07-01 |
| Phase 1/II, Safety and Immunogenicity Study of AERAS-404 in BCG-Primed Infants (NCT01861730) | Aeras | 2013-07-01 |
| HRZE Fasted/Fed in Newly Diagnosed TB (NCT02121314) | University Medical Center Groningen | 2013-07-01 |
| Epidemiology and Diagnosis of Haemoptysis: a Multicenter Study (NCT02045394) | University of Milan | 2013-06-01 |
| Sustainable East Africa Research in Community Health (NCT01864603) | University of California, San Francisco | 2013-04-01 |
| Genome Sequencing of Multidrug Resistant Tuberculosis (MDR TB) in Sputum (NCT02245347) | St George's Healthcare NHS Trust | 2013-04-01 |
| Start TB Patients on ART and Retain on Treatment (START Study) (NCT01872390) | Columbia University | 2013-04-01 |
| Bronchoscopic Sampling Techniques in Sarcoidosis (NCT01836822) | Medical University of Warsaw | 2013-03-01 |
| Rapid Diagnostic Tests and Clinical/Laboratory Predictors of Tropical Diseases In Patients With Persistent Fever in Cambodia, Nepal, Democratic Republic of the Congo and Sudan (NIDIAG-Fever) (NCT01766830) | University Hospital, Geneva | 2013-01-01 |
| Pharmacokinetics of Lopinavir/Ritonavir Superboosting in Infants and Young Children Co-infected With HIV and TB (NCT02348177) | Drugs for Neglected Diseases | 2013-01-01 |
| A Trial of the Urine LAM Strip Test for TB Diagnosis Amongst Hospitalized HIV-infected Patients (NCT01770730) | University of Cape Town | 2013-01-01 |
| Dose-Escalation Study to Evaluate the Safety and Immunogenicity of MTBVAC Vaccine in Comparison With BCG Vaccine. (NCT02013245) | Biofabri, S.L | 2013-01-01 |
| Effect of Filarial Infection on Immune Responses in Latent Tuberculosis (NCT01547884) | National Institute of Allergy and Infectious Diseases (NIAID) | 2013-01-01 |
| Phase 2a EBA Trial of AZD5847 (NCT01516203) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-12-05 |
| Using Entecavir to Reduce Hepatitis in Highly Viremic HBV Patients During Anti-tuberculous Treatment (NCT01724723) | National Taiwan University Hospital | 2012-12-01 |
| Comparative Study of Bacille Calmette Guerin (BCG) Delivery Via Disposable Syringe Jet Injector and Needle & Syringe (NCT01742364) | PATH | 2012-12-01 |
| Siemens VOC TB Pilot Study (NCT01748357) | Research Center Borstel | 2012-12-01 |
| Interaction Study to Assess the Pharmacokinetic Interaction of Oral Administration of Rifapentine on ATRIPLA™ in HIV Patients (NCT01690403) | Sanofi | 2012-12-01 |
| Optimal Dosing of 1st Line Antituberculosis and Antiretroviral Drugs in Children (a Pharmacokinetic Study) (NCT01637558) | University of Cape Town | 2012-11-01 |
| Pharmacokinetics of Levofloxacin and Capreomycin in Multidrug-Resistant Tuberculosis Patients (NCT02169141) | University Medical Center Groningen | 2012-11-01 |
| Prospective Comparison of the Tuberculin Skin Test and Interferon-Gamma Release Assays in Diagnosing Infection With Mycobacterium Tuberculosis and in Predicting Progression to Tuberculosis (NCT01622140) | Centers for Disease Control and Prevention | 2012-10-01 |
| Pharmacokinetics of Anti-TB Drugs in HIV/TB Co-infected Children in Ghana (NCT01687504) | The Miriam Hospital | 2012-10-01 |
| Simplified Severe Sepsis Protocol-2 (SSSP-2) in Zambia (NCT01663701) | Vanderbilt University | 2012-10-01 |
| Rifampin and Efavirenz Interactions in Older Children (NCT01704144) | The Miriam Hospital | 2012-10-01 |
| Rifampin and Nevirapine Interactions in Young Children (NCT01699633) | The Miriam Hospital | 2012-10-01 |
| Effectiveness of Active Case Finding of Household Contacts in a Routine Tuberculosis (TB) Control Program (NCT02174380) | Lena Shah | 2012-10-01 |
| Etiologies, Investigations and Outcomes of Patients Presenting With Hemoptysis (NCT02913365) | Université de Sherbrooke | 2012-10-01 |
| Safety and Immunogenicity of MVA85A Prime and Bacille Calmette-Guerin Boost Vaccination (NCT01650389) | Mark Hatherill | 2012-10-01 |
| Vitamin D Supplementations as Adjunct to Anti-Tuberculosis Drugs in Mongolia (NCT01657656) | Harvard School of Public Health (HSPH) | 2012-10-01 |
| Safety Study of Tuberculosis Vaccines AERAS-402 and MVA85A (NCT01683773) | University of Oxford | 2012-09-01 |
| Effect of PA-824 and of PA-824 Plus Moxifloxacin on the QTc Interval in Healthy Volunteers (NCT01674218) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-09-01 |
| Chepetsa TB - Reducing TB Among HIV-Infected Malawians (NCT01450085) | Johns Hopkins University | 2012-09-01 |
| A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERON®, in Combination With a Safety Assessment of C-Tb Versus Tuberculin PPD RT23 SSI (NCT01642888) | Statens Serum Institut | 2012-09-01 |
| Study in Healthy Adults to Evaluate Gene Activation After Vaccination With GlaxoSmithKline (GSK) Biologicals' Candidate Tuberculosis (TB) Vaccine GSK 692342 (NCT01669096) | GlaxoSmithKline | 2012-08-21 |
| Evaluating Accuracy, Impact, and Operational Challenges of GeneXpert Use for TB Case Finding Among HIV-infected Persons (NCT02538952) | Centers for Disease Control and Prevention | 2012-08-01 |
| Comparison of Diagnostic Performance of C-Tb to QuantiFERON®-TB, in Combination With a Safety Assessment of C-Tb vs Tuberculin PPD RT23 SSI (NCT01631266) | Statens Serum Institut | 2012-07-01 |
| Cell Phone Messaging to Improve Communication of Critical Laboratory Results to Patients in Rural Uganda (NCT01579214) | Massachusetts General Hospital | 2012-07-01 |
| Preliminary Evaluation of a Point-Of-Care Liver Function Test (NCT01705041) | PATH | 2012-06-01 |
| Evaluating the Pharmacokinetics of High-Dose Rifapentine When Given as a Single Dose or in Divided Doses to Healthy Adults (NCT01574638) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-06-01 |
| Determining the Impact of Enhanced Case Finding on Tuberculosis Notification in The Gambia (NCT01660646) | London School of Hygiene and Tropical Medicine | 2012-06-01 |
| Gene Expression in HIV and Tuberculosis Co-infection (NCT01611402) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-05-29 |
| Database of All Patients With Microbiologically Proven Mycobacteria Tuberculosis Infection (NCT01601275) | Singapore General Hospital | 2012-05-01 |
| Evaluating the Safety and Drug Interaction of PA-824, an Investigational Tuberculosis Medication, Together With Efavirenz, Ritonavir-Boosted Lopinavir, or Rifampin (NCT01571414) | National Institute of Allergy and Infectious Diseases (NIAID) | 2012-05-01 |
| Effects of a Protein Calorie Supplement in HIV-infected Women With Tuberculosis (NCT01635153) | Dartmouth-Hitchcock Medical Center | 2012-05-01 |
| Evaluation of Xpert MTB/RIF Assay for the Rapid Identification of TB and TB Rifampin Resistance in Pulmonary Tuberculosis Suspects (NCT01587469) | Cepheid | 2012-05-01 |
| Screening of Children in Household Contact With Adult TB Patients in Mbarara Hospital, Uganda (NCT01492595) | Epicentre | 2012-04-01 |
| An Open Cohort of Childhood Tuberculosis in Mbarara National Referral Hospital, Uganda (NCT01422798) | Epicentre | 2012-04-01 |
| The Usefulness of Interferon-γ Release Assays and Tuberculin Skin Test for Detection of Latent Tuberculosis Infection (NCT01685905) | Hanyang University | 2012-04-01 |
| The Role of IGRA in Screening and Monitoring for TB During Anti TNF Therapy in Patients With IMID (NCT02135289) | Chinese University of Hong Kong | 2012-03-01 |
| Evaluation of a LAM FLISA for the Diagnosis of Tuberculosis (NCT01587677) | Research Center Borstel | 2012-02-01 |
| Xpert MTB/Rif, a New Tool for the Diagnosis of Pulmonary Tuberculosis in Two Municipalities in Brazil (NCT01363765) | Ataulpho de Paiva Foundation | 2012-02-01 |
| The Efficacy of Silymarin on the Prevention of Hepatotoxicity From Antituberculosis Drugs (NCT01800487) | Ramathibodi Hospital | 2012-01-01 |